|
|
||||||||



*
The Hospital For Sick Children, Research Institute, University of Toronto, Toronto, Ontario, Canada;
Departments of Pediatrics and Immunology, Sunnybrook and Womens College Health Sciences Center, and
University of Western Ontario, Department of Immunology, John P. Robarts Research Institute, London, Ontario, Canada
ICA69 (islet cell Ag 69 kDa) is a diabetes-associated autoantigen
with high expression levels in
cells and brain. Its function is
unknown, but knockout of its Caenorhabditis elegans
homologue, ric-19, compromised neurotransmission. We
disrupted the murine gene, ica-1, in 129-strain mice.
These animals aged normally, but speed-congenic ICA69null
nonobese diabetic (NOD) mice developed mid-life lethality, reminiscent
of NOD-specific, late lethal seizures in glutamic acid decarboxylase
65-deficient mice. In contrast to wild-type and heterozygous animals,
ICA69null NOD congenics fail to generate, even after
immunization, cross-reactive T cells that recognize the dominant Tep69
epitope in ICA69, and its environmental mimicry Ag, the ABBOS epitope
in BSA. This antigenic mimicry is thus driven by the endogenous self
Ag, and not initiated by the environmental mimic. Insulitis,
spontaneous, and adoptively transferred diabetes develop normally in
ICA69null NOD congenics. Like glutamic acid decarboxylase
65, ICA69 is not an obligate autoantigen in diabetes. Unexpectedly,
ICA69null NOD mice were resistant to cyclophosphamide
(CY)-accelerated diabetes. Transplantation experiments with hemopoietic
and islet tissue linked CY resistance to ICA69 deficiency in islets.
CY-accelerated diabetes involves not only ablation of lymphoid cells,
but ICA69-dependent drug toxicity in
cells that boosts
autoreactivity in the regenerating lymphoid
system.
This article has been cited by other articles:
![]() |
M. Cao, J. Xu, C. Shen, C. Kam, R. L. Huganir, and J. Xia PICK1 ICA69 Heteromeric BAR Domain Complex Regulates Synaptic Targeting and Surface Expression of AMPA Receptors J. Neurosci., November 21, 2007; 27(47): 12945 - 12956. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yagil, R. Barkalifa, M. Sapojnikov, A. Wechsler, D. Ben-Dor, S. Weksler-Zangen, N. Kaiser, I. Raz, and Y. Yagil Metabolic and genomic dissection of diabetes in the Cohen rat Physiol Genomics, April 24, 2007; 29(2): 181 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vital, E. Larrieta, and M. Hiriart Sexual dimorphism in insulin sensitivity and susceptibility to develop diabetes in rats. J. Endocrinol., August 1, 2006; 190(2): 425 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kubosaki, S. Gross, J. Miura, K. Saeki, M. Zhu, S. Nakamura, W. Hendriks, and A. L. Notkins Targeted Disruption of the IA-2{beta} Gene Causes Glucose Intolerance and Impairs Insulin Secretion but Does Not Prevent the Development of Diabetes in NOD Mice Diabetes, July 1, 2004; 53(7): 1684 - 1691. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Spitzenberger, S. Pietropaolo, P. Verkade, B. Habermann, S. Lacas-Gervais, H. Mziaut, M. Pietropaolo, and M. Solimena Islet Cell Autoantigen of 69 kDa Is an Arfaptin-related Protein Associated with the Golgi Complex of Insulinoma INS-1 Cells J. Biol. Chem., July 3, 2003; 278(28): 26166 - 26173. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |